CombiMatrix Starts Trading on Nasdaq Global Market

Nov 19, 2007

NEW YORK (GenomeWeb News) – CombiMatrix’s stock began trading on the Nasdaq Global Market today.

The stock had been trading on the Nasdaq Capital Market since CombiMatrix split off from its former parent company Acacia Research in August.

CombiMatrix, which now trades under the symbol CBMX, was trading at $6.77 a share late Monday afternoon.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

This Week in Science

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

New Framework Suggested

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

Penguins With Roving Eyes

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Funding Lost

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

Main menu